These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15637527)

  • 21. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
    Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
    Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
    Banfield C; Gupta S; Marino M; Lim J; Affrime M
    Clin Pharmacokinet; 2002; 41(4):311-8. PubMed ID: 11978146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
    Akamine Y; Miura M; Yasui-Furukori N; Ieiri I; Uno T
    J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
    Shimizu M; Uno T; Sugawara K; Tateishi T
    Br J Clin Pharmacol; 2006 Sep; 62(3):372-6. PubMed ID: 16796706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of fexofenadine following LPS administration to rats.
    Jaisue S; Gerber JP; Davey AK
    Xenobiotica; 2010 Nov; 40(11):743-50. PubMed ID: 20863200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
    Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
    Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
    Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
    Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.
    Yamazaki A; Kumagai Y; Yamane N; Tozuka Z; Sugiyama Y; Fujita T; Yokota S; Maeda M
    J Clin Pharm Ther; 2010 Apr; 35(2):169-75. PubMed ID: 20456735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone.
    Lamberg TS; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Jun; 63(6):640-5. PubMed ID: 9663178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.
    Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Houston B; Oosterhuis B; Bjerrum OJ; Rowland M; Garner C
    Eur J Pharm Sci; 2010 May; 40(2):125-31. PubMed ID: 20307657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.
    Sakugawa T; Miura M; Hokama N; Suzuki T; Tateishi T; Uno T
    Br J Clin Pharmacol; 2009 May; 67(5):535-40. PubMed ID: 19552748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.
    Ujie K; Oda M; Kobayashi M; Saitoh H
    Int J Pharm; 2008 Sep; 361(1-2):7-11. PubMed ID: 18572335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
    Cvetkovic M; Leake B; Fromm MF; Wilkinson GR; Kim RB
    Drug Metab Dispos; 1999 Aug; 27(8):866-71. PubMed ID: 10421612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal interaction between itraconazole and cimetidine.
    Karyekar CS; Eddington ND; Briglia A; Gubbins PO; Dowling TC
    J Clin Pharmacol; 2004 Aug; 44(8):919-27. PubMed ID: 15286096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organic anion and cation transporters are possibly involved in renal excretion of entecavir in rats.
    Yanxiao C; Ruijuan X; Jin Y; Lei C; Qian W; Xuefen Y; Hong T; Xueying Z; Davey AK; Jiping W
    Life Sci; 2011 Jul; 89(1-2):1-6. PubMed ID: 21466809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    J Clin Pharmacol; 2005 Jan; 45(1):79-88. PubMed ID: 15601808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation.
    Bedada SK; Appani R; Boga PK
    Drug Dev Ind Pharm; 2017 Jun; 43(6):932-938. PubMed ID: 28102715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.